← FDA DRUG APPROVALS

FDA NDA · NDA012179

VOSOL

Sponsor: HIKMA

APPLICATION
NDA012179
TYPE
NDA
ORIGINAL APPROVAL
1960-05-17
LATEST ACTION
1997-10-16
ROUTE
OTIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

VOSOL · ReferenceDiscontinued
ACETIC ACID, GLACIAL 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION/DROPS · OTIC

Approval history

1997-10-16Manufacturing (CMC) · Supplement 19 · standardAP
1997-07-29Labeling · Supplement 18 · standardAP
1995-12-21Manufacturing (CMC) · Supplement 16 · standardAP
1988-06-29Labeling · Supplement 15AP
1987-08-03Labeling · Supplement 12AP
1986-08-26Manufacturing (CMC) · Supplement 14 · standardAP
1985-06-24Manufacturing (CMC) · Supplement 13 · standardAP
1984-06-06Manufacturing (CMC) · Supplement 11 · standardAP
1984-06-06Labeling · Supplement 8AP
1975-06-02Manufacturing (CMC) · Supplement 6 · standardAP
1974-07-16Supplement · Supplement 5 · standardAP
1960-05-17Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →